Innovations in the Treatment of the Macular Edema in Retinal Venous Occlusions
Authors:
J. Studnička; E. Rencová
Authors‘ workplace:
Oční klinika LF UK a FN, Hradec Králové, přednosta prof. MUDr. Pavel Rozsíval, CSc., FEBO
Published in:
Čes. a slov. Oftal., 67, 2011, No. 4, p. 129-132
Category:
Original Article
Overview
The authors present new possibilities in the treatment of the macular edema caused by the retinal venous occlusions; these occlusions are the second most common retinal vessel disease. The earlier possibilities of the treatment were focused on the macular edema laser treatment, laser panretinal photocoagulation in case of retinal or iris neovascularization presence, and the disease’s risk factors compensation. In the presence, the intravitreal application of corticosteroids or anti VEGF A preparations are more used for the treatment because of better results, as proved by means of randomized, clinical studies.
Key words:
corticosteroids, laser treatment, macular edema, retinal vein occlusion, anti VEGF A
Sources
1. Brown, D.M., Campochiaro, P.A., Singh, R.P. et al.: Ranibizumab for macular edema following central retinal vein occlusion: six-month primary end point results of a phase III study. Ophthalmology, 2010; 117: 1124–1133.
2. Campochiaro, P.A., Heier, J.S., Feiner, L. et al.: Ranibizumab for macular edema following branch retinal vein occlusion: six-month primary end point results of a phase III study. Ophthalmology, 2010; 117: 1102–1112.
3. Haller, J.A., Bandello, F., Belfort, R. Jr. et al.: Randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with macular edema due to retinal vein occlusion. Ophthalmology, 2010; 117(6): 1134–1146.
4. Hattenbach, L.O., Arndt, C.F., Lerche, R. et al.: Retinal vein occlusion and low-dose fibrinolytic therapy (R.O.L.F.): a prospective, randomized, controlled multicenter study of low-dose recombinant tissue plasminogen activator versus hemodilution in retinal vein occlusion. Retina, 2009; 29(7): 932–940.
5. Hayreh, S.S., Zimmerman, B., Masirthy, M.J. et al.: Systemic diseases associated with various types of retinal vein occlusion. Am. J. Ophthalmol, 2001; 131: 61–77.
6. Cheung, N., Klein, R., Wang, J.J. et al.: Traditional and novel cardiovascular risk factors for retinal vein occlusion: the multiethnic study of atherosclerosis. Invest. Ophthalmol. Vis. Sci., 2008; 49: 4297–4302.
7. Jalkh, A.E., Avila, P.M., Zakka, K.A. et al.: Chronic macular edema in retinal branch vein occlusion: Role of laser photocoagulation. Ann Ophthalmol, 1984; 16: 526–533.
8. Kinge, B., Stordahl, P.B., Vegard, F. et al: Efficacy of ranibizumab in patients with macular edema secondary to central retinal vein occlusion: results form the sham-controlled ROCC study. Am J Ophthalmol, 2010; 150: 310–314.
9. L’Esperance, F.A.: Ocular photocoagulation. A stereoscopic atlas. Mosby Company, 1975, 337.
10. McAllister, I.L., Constable, I.J.: Laser-induced chorioretinal venous anastomosis for treatment of nonischemic central retinal vein occlusion. Arch Ophthalmol, 1995: 456–462.
11. McIntosh, R.L., Rogers, S.L., Lim, L. et al.: Natural history of central retinal vein occlusion: an evidence-based systematic review. Ophthalmology, 2010, 117(6), 1113–1123.
12. O’Mahoney, P.R., Wong, D.T., Ray, J.G.: Retinal vein occlusion and traditional risk factors for atherosclerosis. Arch. Ophthalmol., 2008, 126, 692–699.
13. Opremcak, E.M., Bruce, R.A.: Surgical decompression of branch retinal vein occlusion via arteriovenous crossing. Retina, 1999, 19, 1–5.
14. Opremcak, E.M., Bruce, R.A., Lomeo, M.D. et al.: Radial optic neurotomy for central retinal vein occlusion: A retrospective pilot study of 11 consecutive cases. Retina, 2001; 21: 408–415.
15. Osterloh, M.D., Charles, S.: Surgical decompression of branch retinal vein occlusion. Arch. Ophthalmol., 1988; 106: 1469–1471.
16. Rath, E.Z., Frank, R.N., Shin, D.H. et al.: Risk factors for retinal vein occlusions. A case-control study. Ophthalmology, 1992; 99: 509–514.
17. Rogers, S.L., McIntosh, R.L., Lim, L. et al.: Natural history of branch retinal vein occlusion: an evidence-based systematic review. Ophthalmology, 2010; 117(6): 1094–1101.
18. Řehák, J., Chrapek, O.: Venózní okluze sítnice. In: Trendy soudobé oftalmologie sv. 2, Praha, Galén, 2005, 75–98.
19. Řehák, J., Rehák, M. et al.: Venózní okluze sítnice. Grada Publishing, a.s., 2011, s. 144, ISBN 978-80-247-3480-4.
20. Řehák, J., Vymazal, M.: Arteriolární konstrikce v léčbě okluze větve sítnicové vény. Čs Oftalmol,1993, 49, 155–159.
21. Scott, I.U., Ip, M.S., VanVeldhuisen, P.C. et al.: SCORE Study Research Group. A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with standard care to treat vision loss associated with macular edema secondary to branch retinal vein occlusion: the Standard Care vs. Corticosteroid for Retinal Vein Occlusion (SCORE) study report 6. Arch Ophthalmol. 2009, 127(9), 1115–1128.
22. Shah, G.K., Sharma, S., Fineman, M.S. et al.: Arteriovenous adventitial sheathotomy for treatment of macular edema associated with branch retinal vein occlusion. Am J Ophthalmol, 2000, 129, 104–106.
23. The branch vein occlusion study group: Argon laser photocoagulation for macular edema in branch retinal vein occlusion. Am J Ophthalmol, 1984; 98: 271–282.
24. The central vein occlusion study group: Evaluation of grid pattern photocoagulation for macular edema in central vein occlusion. Ophthalmology 1995; 102: 1425–1433.
25. Wroblewski, J.J., Wells, J.A. 3rd, Adamis, A.P. et al: Pegaptanib sodium for macular edema secondary central retinal vein occlusion. Arch Ophthalmol, 2009; 127(4): 374–380.
26. Wroblewski, J.J., Wells, J.A. 3rd, Gonzales, C.R.: Pegaptanib sodium for macular edema secondary branch retinal vein occlusion. Am J Ophthalmol, 2010; 149(1): 147–154.
27. Wu, L., Arevalo, J.F., Berrocal, M.H. et al.: Comparison of two doses of intravitreal bevacizumab as primary treatment for macular edema secondary to branch retinal vein occlusions: results of the Pan American Collaborative Retina Study Group at 24 months. Retina, 2009; 29(10): 1396–403.
28. Wu, L., Arevalo, J.F., Berrocal, M.H. et al.: Comparison of two doses of intravitreal bevacizumab as primary treatment for macular edema secondary to central retinal vein occlusions: results of the Pan American Collaborative Retina Study Group at 24 months. Retina, 2010; 30(7): 1002–1011.
Labels
OphthalmologyArticle was published in
Czech and Slovak Ophthalmology
2011 Issue 4
Most read in this issue
- Unilateral Cystoid Macular Edema Induced by Citalopram – a Case Report
- Morphologic Changes of Anterior Segment of the Eye after Cataract Surgery
- Long Term Results of Laser Refractive Operations – Methods Epi-LASIK or LASEK
- Retinitis Septica Roth – a Case Report